Journal article icon

Journal article

Using a Markov model and real-world evidence to identify the most cost-effective cholesterol treatment escalation threshold for the secondary prevention of cardiovascular disease

Abstract:
Background

Despite the decreased risk of cardiovascular disease (CVD) with statins, there remains an unfulfilled clinical need to prevent CVD events and premature mortality through further cholesterol-modifying interventions. In people with established CVD taking a statin, lipid therapy escalation to reduce low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (non-HDL-C) levels may lower the risk of CVD hospital admissions and improve su...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s40258-025-00977-6

Authors

More by this author
Role:
Author
ORCID:
0009-0006-6405-304X


Publisher:
Springer Nature
Journal:
Applied Health Economics and Health Policy More from this journal
Volume:
23
Issue:
5
Pages:
869–883
Publication date:
2025-05-24
Acceptance date:
2025-05-04
DOI:
EISSN:
1179-1896
ISSN:
1175-5652


Language:
English
Pubs id:
2126942
Local pid:
pubs:2126942
Deposit date:
2025-05-28
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP